Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus Infection
Kingshuk Panda, Deepti Parashar, Rajlakshmi Viswanathan
Viruses (2023) Vol. 15, Iss. 6, pp. 1358-1358
Open Access | Times Cited: 15

Showing 15 citing articles:

Human Cytomegalovirus (HCMV) Genetic Diversity, Drug Resistance Testing and Prevalence of the Resistance Mutations: A Literature Review
Ivana Grgić, Lana Gorenec
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 2, pp. 49-49
Open Access | Times Cited: 7
Insights into novel inhibitors intending HCMV Protease a computational molecular modelling investigation for antiviral drug repurposing
Noimul Hasan Siddiquee, Afsan Ara Tanni, Nikkon Sarker, et al.
Informatics in Medicine Unlocked (2024) Vol. 48, pp. 101522-101522
Open Access | Times Cited: 6
Recent HCMV infection in early pregnancy associates with congenital transmission & adverse pregnancy outcome: A prospective cohort study
Harsha Palav, Varsha Padwal, Shilpa Velhal, et al.
The Indian Journal of Medical Research (2025) Vol. 160, pp. 614-624
Open Access
Ganciclovir Resistance-Linked Mutations in the HCMV UL97 Gene: Sanger Sequencing Analysis in Samples from Transplant Recipients at a Tertiary Hospital in Southern Brazil
Anna Caroline Avila da Rocha, Grazielle Motta Rodrigues, Alessandra Helena da Silva Hellwig, et al.
Diagnostics (2025) Vol. 15, Iss. 2, pp. 214-214
Open Access
Antiviral Approach to Cytomegalovirus Infection: An Overview of Conventional and Novel Strategies
Paolo Bottino, Lisa Pastrone, Antonio Curtoni, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2372-2372
Open Access | Times Cited: 8
Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers
Markus Wild, Dubravka Karner, Jan Eickhoff, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2680-2680
Open Access | Times Cited: 6
SiRNAs as antiviral drugs – Current status, therapeutic potential and challenges.
Trairong Chokwassanasakulkit, Victor B. Oti, Adi Idris, et al.
Antiviral Research (2024), pp. 106024-106024
Open Access | Times Cited: 1
Refractory human cytomegalovirus infection without evidence of genetic resistance in the UL-54 and UL-97 genes in a pediatric hematopoietic stem cell transplant recipient: a case report
Alejandra Pando-Caciano, Ketty Adid Escudero-Ramirez, Jackeline Carol Torres-Rodríguez, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Enhanced Immunomodulatory Effects of Thymosin-Alpha-1 in Combination with Polyanionic Carbosilane Dendrimers against HCMV Infection
María de la Sierra Espinar-Buitrago, Esmeralda Magro-López, Elena Vázquez‐Alejo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1952-1952
Open Access
N-Arylpyrimidinamine (Napa) Compounds are Broadly Acting Inhibitors of Human Cytomegalovirus Infection and Proliferation
Kristina E. Atanasoff, Sabrina I. Ophir, Andrea Parsons, et al.
(2024)
Closed Access
Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation
Tang‐Her Jaing, Yi-Lun Wang, Chia-Chi Chiu
Viruses (2024) Vol. 16, Iss. 8, pp. 1268-1268
Open Access
Efficacy of Letermovir for CMV Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant.
Ibrahim N. Muhsen, Kristen Shaver, Tao Wang, et al.
Transplantation and Cellular Therapy (2024)
Closed Access
N-arylpyrimidinamine (NAPA) compounds are broadly acting inhibitors of human cytomegalovirus infection and spread
Kristina E. Atanasoff, Sabrina I. Ophir, Andrea Parsons, et al.
Antiviral Research (2024) Vol. 233, pp. 106044-106044
Closed Access
Third intracellular loop of HCMV US28 is necessary for signaling and viral reactivation
Samuel Medica, Michael Denton, Nicole L. Diggins, et al.
Journal of Virology (2024) Vol. 99, Iss. 1
Open Access
Macrophage colony‐stimulating factor as a weapon against cytomegalovirus
Éric Solary
EMBO Molecular Medicine (2023) Vol. 15, Iss. 11
Open Access | Times Cited: 1
Page 1

Scroll to top